...
首页> 外文期刊>Diabetes, metabolic syndrome and obesity: targets and therapy >Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria
【24h】

Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria

机译:尿细胞外囊中的α1-抗酸酐素:在微白蛋白尿之前的糖尿病肾病的潜在生物标志物

获取原文
           

摘要

Purpose: Diabetic kidney disease (DKD), which is related to inflammation and immune response, is the primary vascular complication of diabetes mellitus and also the leading etiology of end-stage renal disease. Urinary extracellular vesicles (UEVs) are an attractive source for biomarker detection as they involve molecular constituents derived from their parental sections of the nephron. In this study, we aimed to search for a potential biomarker in UEVs for the early diagnosis and prediction of DKD, especially before the emergence of microalbuminuria. Patients and Methods: UEVs were isolated from the urine of healthy subjects, pre-diabetic, and diabetic patients with varying degrees of kidney damage by ultracentrifugation, and the extracted UEVs were used to measure alpha1-antitrypsin (α 1-AT) by Western blot. To explore the function of α 1-AT in the inflammatory process leading to DKD, we silenced the expression of α 1-AT in renal tubular epithelial cells using cell transfection techniques to assess the differential expression of the inflammatory factors such as MCP-1 and TNF-α using qRT-PCR. Results: There was no expression of α 1-AT in the UEVs of either healthy or pre-diabetic subjects. Its expression was significantly increased in the UEVs of diabetic patients with normoalbuminuria (prior to microalbuminuria), which was more sensitive and more stable than other renal indexes to predict DKD. Additionally, the expression of α 1-AT in UEVs was gradually upregulated with the aggravation of DKD and the decline of renal function. In vitro, the mRNA expression of MCP-1 and TNF-α was significantly decreased when the generation of α 1-AT in tubular epithelial cells was inhibited under high glucose stimulation. Conclusion: Our results suggest that α 1-AT derived from UEVs, especially in diabetic patients with normoalbuminuria, might serve as a potential noninvasive biomarker for diagnosis of DKD early in the development of the disease and may predict the future decline of renal function.
机译:目的:与炎症和免疫应答有关的糖尿病肾疾病(DKD)是糖尿病糖尿病的主要血管并发症,也是末期肾病的主要病因。尿细胞外囊泡(UEV)是生物标志物检测的有吸引力的来源,因为它们涉及来自肾上腺父母部分的分子成分。在这项研究中,我们旨在在uevs中寻找潜在的生物标志物,用于对DKD的早期诊断和预测,特别是在微白蛋白尿的出现之前。患者和方法:UEVs与健康受试者,前糖尿病患者和糖尿病患者的尿液中的尿液中患者通过超速离心损伤的尿液中分离出来,用蛋白质印迹使用提取的UEV来测量α1-antikrypsin(α1-at) 。为了探讨α1-in的炎症过程中导致DKD的功能,我们使用细胞转染技术静音肾小管上皮细胞中α1-静脉的表达,以评估MCP-1等炎症因素的差异表达使用QRT-PCR的TNF-α。结果:健康或前糖尿病患者的UEV中没有表达α1-α.糖尿病患者的UEV患者(在微蛋白核桃之前)的UEV中,其表达显着增加,这比其他肾指数更敏感,更稳定,以预测DKD。另外,随着DKD的加长和肾功能的衰退,α1-α1-α1-α1-in的表达逐渐上调。在体外,当在高葡萄糖刺激下抑制α1-inα1-静脉中的α1-inα.抑制时,MCP-1和TNF-α的mRNA表达显着降低。结论:我们的研究结果表明,α1-源于UEVS,特别是在糖尿病患者中患有Namoalbuminuria的糖尿病患者,可能是潜在的非侵入性生物标志物,用于诊断疾病的发展早期,并可能预测肾功能的未来下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号